The Centre for Infectious Disease Research in Zambia is a non-profit organisation founded in 2001 as collaboration between the University of Alabama at Birmingham, USA, the Ministry of Health of Zambia and the University of Zambia School of Medicine.

During the past decade, Centre for Infectious Disease Research in Zambia conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 4 clinical trials were completed, i.e. on average, 21.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre for Infectious Disease Research in Zambia" #1 sponsor was "University of North Carolina, Chapel Hill" with 12 trials, followed by "University of Alabama at Birmingham" with 5 trials sponsored, "Centre for Infectious Disease Research in Zambia" with 4 trials sponsored, "University of Bern" with 2 trials sponsored and "AIDS Clinical Trials Group" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre for Infectious Disease Research in Zambia" #1 collaborator was "Centre for Infectious Disease Research in Zambia" with 9 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials as a collaborator, "Centers for Disease Control and Prevention" with 3 trials as a collaborator, "Doris Duke Charitable Foundation" with 3 trials as a collaborator and "Johns Hopkins University" with 3 trials as a collaborator. Other collaborators include 46 different institutions and companies that were collaborators in the rest 51 trials.

According to Clinical.Site data, the most researched conditions in "Centre for Infectious Disease Research in Zambia" are "HIV" (7 trials), "HIV Infections" (4 trials), "Depression" (3 trials), "Alcohol Use Disorder" (2 trials) and "HIV Infection" (2 trials). Many other conditions were trialed in "Centre for Infectious Disease Research in Zambia" in a lesser frequency.

Most popular intervention types in "Centre for Infectious Disease Research in Zambia" are "Other" (10 trials), "Drug" (6 trials), "Behavioral" (5 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Acyclovir" (1 trials), "Ad26.Mos4.HIV" (1 trials), "Anti-HIV Agents" (1 trials) and "BEHAVIOURAL CHANGE CAMPAIGN FOR COVID-19 PREVENTION IN ZAMBIA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre for Infectious Disease Research in Zambia" are 22 trials for "All" genders, 8 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centre for Infectious Disease Research in Zambia". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Centre for Infectious Disease Research in Zambia, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centre for Infectious Disease Research in Zambia, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 13 trials that are defined as “Not Applicable".